|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
11/2/2006 11:11:25 AM
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has extended the initial expiration date for its previously announced tender offer for all of the outstanding shares of common stock of Myogen, Inc. (Nasdaq: MYOG) to Monday, November 13, 2006 at one minute following 11:59 p.m. New York City time (midnight). The originally announced expiration date for the tender offer, Friday, November 10, 2006, is a federal employee holiday. Therefore, the initial expiration date for the tender offer is being corrected and extended in order to ensure that the tender offer will remain open for the full minimum twenty business-day period required under Rule 14e-1 of the Securities Exchange Act of 1934, as amended.
|
|
|
|
|
|
|
|
|
|
|